Five-minute point-of-care testing for SARS-CoV-2: Not there yet

doi:10.1016/j.jcv.2020.104410

Comparative Study

. 2020 Jul:128:104410.

doi: 10.1016/j.jcv.2020.104410. Epub 2020 May 1.

Five-minute point-of-care testing for SARS-CoV-2: Not there yet

Catherine A Hogan¹, Malaya K Sahoo², ChunHong Huang², Natasha Garamani², Bryan Stevens¹, James Zehnder², Benjamin A Pinsky³

Affiliations

¹ Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Clinical Virology Laboratory, Stanford Health Care, Stanford, CA, USA.
² Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
³ Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Clinical Virology Laboratory, Stanford Health Care, Stanford, CA, USA; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: bpinsky@stanford.edu.

PMID: 32403009
PMCID: PMC7194071
DOI: 10.1016/j.jcv.2020.104410

Comparative Study

Five-minute point-of-care testing for SARS-CoV-2: Not there yet

Catherine A Hogan et al. J Clin Virol. 2020 Jul.

. 2020 Jul:128:104410.

doi: 10.1016/j.jcv.2020.104410. Epub 2020 May 1.

Authors

Catherine A Hogan¹, Malaya K Sahoo², ChunHong Huang², Natasha Garamani², Bryan Stevens¹, James Zehnder², Benjamin A Pinsky³

Affiliations

¹ Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Clinical Virology Laboratory, Stanford Health Care, Stanford, CA, USA.
² Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
³ Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Clinical Virology Laboratory, Stanford Health Care, Stanford, CA, USA; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: bpinsky@stanford.edu.

PMID: 32403009
PMCID: PMC7194071
DOI: 10.1016/j.jcv.2020.104410

No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations of Competing Interest None.

Cited by

Infection precautions for severe acute respiratory syndrome coronavirus 2 in assisted reproduction centers: dodging an invisible bullet.
Sparks AET, Kresowik JD. Sparks AET, et al. Fertil Steril. 2021 Apr;115(4):831-839. doi: 10.1016/j.fertnstert.2021.01.016. Epub 2021 Jan 14. Fertil Steril. 2021. PMID: 33750621 Free PMC article. Review.
Considerations for the selection of tests for SARS-CoV-2 molecular diagnostics.
Erbak Yılmaz H, Iscan E, Oz O, Batur T, Erdoğan A, Kılıç S, Mutlu Z, Yılmaz M, Spring KJ. Erbak Yılmaz H, et al. Mol Biol Rep. 2022 Oct;49(10):9725-9735. doi: 10.1007/s11033-022-07455-5. Epub 2022 Apr 20. Mol Biol Rep. 2022. PMID: 35441938 Free PMC article. Review.
The estimation of diagnostic accuracy of tests for COVID-19: A scoping review.
Axell-House DB, Lavingia R, Rafferty M, Clark E, Amirian ES, Chiao EY. Axell-House DB, et al. J Infect. 2020 Nov;81(5):681-697. doi: 10.1016/j.jinf.2020.08.043. Epub 2020 Aug 31. J Infect. 2020. PMID: 32882315 Free PMC article.
Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.
Lee J, Song JU. Lee J, et al. J Med Virol. 2021 Jul;93(7):4523-4531. doi: 10.1002/jmv.26994. Epub 2021 May 3. J Med Virol. 2021. PMID: 33913533 Free PMC article.
A smartphone-read ultrasensitive and quantitative saliva test for COVID-19.
Ning B, Yu T, Zhang S, Huang Z, Tian D, Lin Z, Niu A, Golden N, Hensley K, Threeton B, Lyon CJ, Yin XM, Roy CJ, Saba NS, Rappaport J, Wei Q, Hu TY. Ning B, et al. Sci Adv. 2021 Jan 8;7(2):eabe3703. doi: 10.1126/sciadv.abe3703. Print 2021 Jan. Sci Adv. 2021. PMID: 33310733 Free PMC article.

See all "Cited by" articles

References

1. ID NOW™ COVID-19. (Accessed 9 April 2020, at https://www.alere.com/en/home/product-details/id-now-covid-19.html).
1. ID NOW COVID-19 - Letter of Authorization. 2020. (Accessed 9 April2020, at https://www.fda.gov/media/136522/download).
1. 2020. Stanford Health Care Clinical Virology Laboratory SARS-CoV-2 Test EUA Summary. (Accessed April 10 2020, at https://www.fda.gov/media/136818/download)
1. Hogan C.A., Sahoo M.K., Huang C. Comparison of the panther fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2. J. Clin. Virol. 2020:104383. - PMC - PubMed
1. Rhoads D.D., Cherian S.S., Roman K., Stempak L.M., Schmotzer C.L., Sadri N. Comparison of Abbott ID now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19. J. Clin. Microbiol. 2020 doi: 10.1128/JCM.00760-20. JCM.00760-20. - DOI - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] ID NOW™ COVID-19. (Accessed 9 April 2020, at https://www.alere.com/en/home/product-details/id-now-covid-19.html).

[2] ID NOW™ COVID-19. (Accessed 9 April 2020, at https://www.alere.com/en/home/product-details/id-now-covid-19.html).

[3] ID NOW COVID-19 - Letter of Authorization. 2020. (Accessed 9 April2020, at https://www.fda.gov/media/136522/download).

[4] ID NOW COVID-19 - Letter of Authorization. 2020. (Accessed 9 April2020, at https://www.fda.gov/media/136522/download).

[5] 2020. Stanford Health Care Clinical Virology Laboratory SARS-CoV-2 Test EUA Summary. (Accessed April 10 2020, at https://www.fda.gov/media/136818/download)

[6] 2020. Stanford Health Care Clinical Virology Laboratory SARS-CoV-2 Test EUA Summary. (Accessed April 10 2020, at https://www.fda.gov/media/136818/download)

[7] Hogan C.A., Sahoo M.K., Huang C. Comparison of the panther fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2. J. Clin. Virol. 2020:104383. - PMC - PubMed

[8] Hogan C.A., Sahoo M.K., Huang C. Comparison of the panther fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2. J. Clin. Virol. 2020:104383. - PMC - PubMed

[9] Rhoads D.D., Cherian S.S., Roman K., Stempak L.M., Schmotzer C.L., Sadri N. Comparison of Abbott ID now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19. J. Clin. Microbiol. 2020 doi: 10.1128/JCM.00760-20. JCM.00760-20. - DOI - PMC - PubMed

[10] Rhoads D.D., Cherian S.S., Roman K., Stempak L.M., Schmotzer C.L., Sadri N. Comparison of Abbott ID now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19. J. Clin. Microbiol. 2020 doi: 10.1128/JCM.00760-20. JCM.00760-20. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Five-minute point-of-care testing for SARS-CoV-2: Not there yet

Affiliations

Five-minute point-of-care testing for SARS-CoV-2: Not there yet

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous